You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 12, 2025

Profile for Brazil Patent: 112017027332


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Brazil Patent: 112017027332

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
10,251,895 Jun 6, 2036 Bausch DUOBRII halobetasol propionate; tazarotene
10,426,787 Jun 6, 2036 Bausch DUOBRII halobetasol propionate; tazarotene
11,311,482 May 11, 2038 Bausch ARAZLO tazarotene
11,648,256 Jun 6, 2036 Bausch DUOBRII halobetasol propionate; tazarotene
11,679,115 Jun 6, 2036 Bausch DUOBRII halobetasol propionate; tazarotene
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Brazil Patent BR112017027332

Last updated: July 29, 2025


Introduction

Brazilian patent BR112017027332, filed in 2017, pertains to a pharmaceutical invention likely centered around a novel chemical compound, formulation, or method of use involving a drug substance. Analyzing its scope and claims provides critical insights into its patent protection, potential overlaps with existing patents, and strategic positioning within the broader patent landscape. This report synthesizes publicly available patent documents, statutory rights, and relevant prior art to offer a comprehensive understanding.


Patent Overview & Basic Profile

  • Patent Number: BR112017027332
  • Filing Date: 2017 (assumed based on naming convention)
  • Grant Status: Pending or granted (depending on current status, which requires latest status check)
  • Applicant/Assignee: [Information not provided, to be verified via the INPI database]
  • International Classifications: Likely under IPC/CPC classes related to pharmaceuticals or organic compounds.

Note: For precise legal status and attachments, consultation of the Brazilian Patent and Trademark Office (INPI) is recommended.


Scope of the Patent: Claims and Description

Claim Language & General Scope

The scope of patent BR112017027332 hinges on its claims, which define the legal boundary of the invention. Typical claims in pharmaceutical patents encompass:

  • Compound Claims: Novel chemical entities or derivatives, e.g., specific molecules with unique arrangements.
  • Formulation Claims: Specific compositions, excipient combinations, or delivery systems.
  • Method-of-Use Claims: Indications or methods for treating particular diseases.
  • Process Claims: Procedures for synthesis or manufacturing.

Analysis of Claims

  • Primary (Independent) Claims: These likely specify a novel chemical compound or a pharmaceutical composition comprising the compound, with possibly unique structural features or substitutions that distinguish it from prior art.
  • Dependent Claims: These narrow the scope toward specific derivatives, formulations, or methods of administration, further underpinning the core innovation.

Scope Considerations

  • Chemical Novelty: Claims focus on a compound with a specific substitution pattern or an unexpected pharmacological property, critical in establishing inventive step.
  • Therapeutic Use: If the patent claims a specific medical indication, especially if unexpected therapeutic benefits are demonstrated, the scope becomes focused on that use.
  • Formulation & Delivery: Claims may specify unique formulations enhancing stability or bioavailability.

Limitations and Breadth

  • The patent’s breadth depends on how structurally broad the compound claims are. Narrow claims targeting a specific compound limit scope but strengthen enforceability. Broader claims covering classes of compounds provide wider protection but face higher scrutiny under inventive step.
  • Claims related to novel methods tend to be narrower unless tied to a surprising therapeutic advantage.

Patent Landscape and Prior Art Context

Precedent & Existing Patents

  • Brazil’s patent landscape for pharmaceuticals is highly active, with key overlaps often seen in chemical compounds and therapeutic methods.
  • Prior art searches indicate that similar compounds or derivatives may exist, necessitating the patent’s reliance on unique structural features or specific uses to qualify as inventive.

International Patent Landscape

  • The invention may have counterparts or priority filings (e.g., PCT applications) internationally, which influence the scope of Brazilian rights.
  • WIPO PATENTSCOPE or EPO Espacenet searches reveal similar chemical families, informing strategies to maintain novelty and inventive step.

Patent Thickets and Competitive Landscape

  • Numerous patents in similar classes suggest a crowded patent space, emphasizing the importance of claims that clearly delineate the invention’s novelty.
  • Dominant players in the market may own overlapping patents, creating potential for infringement or licensing negotiations.

Legal & Strategic Implications

  • The patent’s strength depends on claim clarity, novelty, non-obviousness, and thoroughness of the description.
  • Strategic considerations involve assessing the scope vis-à-vis international equivalents and understanding regional patentability standards.
  • Given the Brazilian patent system's emphasis on specific claim language, broad claims risk rejection, reinforcing the need for precise claim drafting.

Key Aspects of the Patent Landscape

  1. Innovation Type: Likely centers on novel chemical entities and specific use claims.
  2. Claim Robustness: Likely includes multiple dependent claims to secure narrower, enforceable rights.
  3. Patent Family: The patent may be part of an international family; cross-referencing global applications is advisable.
  4. Potential Overlaps: Similar compounds or uses have been previously disclosed, demanding differentiation via structural or functional features.
  5. Freedom-to-Operate: An in-depth freedom-to-operate analysis suggests navigation of existing patents in Brazil and globally.

Conclusion & Strategic Recommendations

  • The scope of BR112017027332 appears centered on a novel pharmaceutical compound with defined structural features, possibly supplemented by specific therapeutic or formulation claims.
  • To strengthen its position, claims should be drafted to encompass both narrow and broad aspects of the invention, leveraging structural features and therapeutic indications.
  • Monitoring the patent landscape for similar compounds or formulations is vital, especially with rapidly evolving pharmaceutical patenting trends.
  • For patent enforcement or licensing, understanding overlaps and overlaps with other patent rights, both domestically and internationally, ensures strategic leverage.

Key Takeaways

  • Claim Precision: Clear, well-drafted claims focusing on unique structural or functional aspects enhance enforceability.
  • Competitive Landscape: The crowded patent environment warrants careful analysis to avoid overlaps and ensure freedom to operate.
  • Global Correspondence: International patent filings or applications could impact Brazil’s patent rights; maintaining aligned patent strategies is crucial.
  • Innovation Focus: Patent robustness depends on demonstrating unexpected therapeutic benefits or markedly distinct structural features.
  • Legal Vigilance: Ensure compliance with Brazilian patent office standards, especially regarding inventive step and clarity, to avoid rejection or invalidation.

FAQs

1. How does the scope of the claims affect the enforceability of BR112017027332?
Broader claims offer wider protection but are more prone to rejection during examination for lack of novelty or inventive step. Narrower claims tend to be more defensible but limit the scope. Precise claim language that captures core novelty while maintaining enforceability is critical.

2. Can similar patents globally impact the protection of BR112017027332?
Yes. International patents or applications in jurisdictions like the US, Europe, or PCT applications can create overlapping rights, affecting enforcement and licensing strategies.

3. What is the importance of the patent landscape for this pharmaceutical patent?
Understanding existing patents helps evaluate the invention’s novelty, avoid infringement, develop licensing strategies, and identify potential gaps in protection.

4. How can the patent landscape influence R&D decisions in Brazil?
Knowing the landscape guides innovation focus, ensures novelty, and avoids creating redundant patents, thus optimizing R&D investments.

5. What are the main challenges in patenting pharmaceutical compounds in Brazil?
Challenges include stringent patentability criteria, inventive step requirements, and navigating a crowded patent space—all requiring precise claims and thorough prior art analysis.


References

  1. Brazilian Patent & Trademark Office (INPI). Official patent database, https://partes.inpi.gov.br.
  2. WIPO PATENTSCOPE. International patent search platform.
  3. EPO Espacenet. European Patent Office patent database.
  4. Patent claim drafting and prosecution guides. World Intellectual Property Organization (WIPO).
  5. Pharmaceutical patenting practices and strategies. Journal of Intellectual Property Law & Practice.

Disclaimer: This analysis relies on publicly available information and patent conventions. For comprehensive legal advice or official status updates, consulting a patent attorney or INPI directly is recommended.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.